Spineway SA (EPA: ALSPW)

Market Cap	23.70M
Revenue (ttm)	11.99M
Net Income (ttm)	-8.00M
Shares Out	278.82M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	835,155
Open	0.0950
Previous Close	0.0832
Day's Range	0.0847 - 0.0950
52-Week Range	0.0730 - 30.0000
Beta	1.36
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 24, 2024

About Spineway

Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; posterior osteosynthesis systems; kili, an anterior lumbar interbody fusion cage; twin peaks plif posterior lumbar interbody fus...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 54
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALSPW

Financial Performance

In 2023, Spineway's revenue was 11.36 million, an increase of 31.34% compared to the previous year's 8.65 million. Losses were -6.51 million, 107.5% more than in 2022.